Mice with homologous disruption of the gene coding for the ligand-binding chain of the interferon (IFN) 3' receptor and derived from a strain genetically resistant to infection with Leishmania major have been used to study further the role of this cytokine in the differentiation of functional CD4 + T cell subsets in vivo and resistance to infection. Wild-type 129/Sv/Ev mice are resistant to infection with this parasite, developing only small lesions, which resolve spontaneously within 6 wk. In contrast, mice lacking the IFN-3, receptor develop large, progressing lesions. After infection, lymph nodes (LN) and spleens from both wild-type and knockout mice showed an expansion of CD4 § cells producing IFN-3, as revealed by measuring IFN-3, in supernatants of specifically stimulated CD4 + T cells, by enumerating IFN-3,-producing T cells, and by Northern blot analysis of IFN-v transcripts. No biologically active interleukin (IL) 4 was detected in supernatants of in vitro-stimulated LN or spleen cells from infected wild-type or deficient mice. Reverse transcription polymerase chain reaction analysis with primers specific for IL-4 showed similar IL-4 message levels in LN from both types of mice. The IL-4 message levels observed were comparable to those found in similarly infected C57BL/6 mice and significantly lower than the levels found in BALB/c mice. Anti-IFN-3" treatment of both types of mice failed to alter the pattern of cytokines produced after infection. These data show that even in the absence of IFN-v receptors, T helper cell (Th) 1-type responses still develop in genetically resistant mice with no evidence for the expansion of Th2 cells.
I
nfection of mice with the protozoan parasite Leishmania major has been used as a model system for the study of the effector functions of IFN-3, and other lymphokines against intracellular microorganisms. Several findings have already dearly demonstrated the importance of IFN-'y for the elimination of L. major by infected hosts. Results from several laboratories have documented that, when treated with anti-IFN-'y neutralizing antibodies, mice normally resistant to infection with L. major are not able to control this infection (1, 2) . In addition, the destruction ofintracellular leishmania by mufine macrophages was shown to result from the IFN-y-induced production of nitric oxide (NO) by these cells (3, 4) .
After infection of mice from various inbred strains with L. major, the parasite burden and the resulting pattern of disease correlates with the expansion of CD4 + T cells from a particular functional subset. Resistance to infection with L. major, which characterizes mice from several inbred strains (CBA, C57BL/6, etc.) has been shown to correlate with the selective triggering of a Thl CD4 + T cell response and results at least in part from the activity of these cells. In contrast, the susceptibility of BALB/c mice results from the preferential expansion and activity of Th2-type T cells (5, 6) .
Thus, the mouse model of infection with L. major has been instrumental in the elucidation of some of the mechanisms controlling the development of polarized Thl versus Th2 responses during antigenic stimulation. In this context, studies have already underlined the importance that cytokines, present at the early stage of infection with L. major, could have on the differentiation of CD4 + T cell precursors toward one or the other functional phenotype. Administration of anti-IFN-3, mAb to genetically resistant mice was shown to interfere with the development of a Thl-type response and to promote the differentiation of a Th2-type response (7) . Similarly, treatment of susceptible BALB/c mice with anti-IL-4 mAbs at an early stage of infection hampers the expansion of Th2 cells, allowing the development of a Thl-type response (8) . Administration of exogenous IFN-y at the initiation of infection transiently reversed the Th2-type response normally displayed by T lymphocytes from susceptible mice (7) . Similarly, the injection of recombinant IL-4 to resistant mice at the time of infection led to the transient development of a Th2-type response (9) . Taken together, these data indicate that IFN-3, and IL-4 play a pivotal role in the development of polarized Thl and Th2 responses, respectively, in this model of infection. The role of IL-4 in the generation of a Th2-type response is also supported by several observations made both in vitro and in vivo in mitogen-or nominal antigen-driven responses (10) (11) (12) (13) . However, the data concerning the importance of IFN-3' in promoting the expansion of Thl cells and inhibiting the development of Th2-type response are still conflicting (10, (12) (13) (14) (15) .
Recently, transgenic mice that lack the IFN-~/R have been produced, offering the possibility to elucidate further the effector and the regulatory functions of IFN-y (16) . In this study, we investigated the course of disease and the functional characteristics of the CD4 + T cell responses triggered after infection with L. major of mice from a genetically resistant background lacking the IFN-qrR.
Materials and Methods
Mice. 129/Sv/Ev mice of either sex homozygous for disrupted IFN-3'R gene (IFN-3"R -/-) and for null mutation (IFN-3,R +/+) were produced as described (16) and maintained under pathogenflee conditions until use at 6-10 wk of age. BALB/c and C57BL/6 mice of the same age (IFFA Credo, Saint-Germain-sur-l'Abresle, France) were used in some experiments.
Parasites and Infection of Mic~ L. major LV 39 (MRHO/SU/59/Pstrain) were maintained in vivo and grown in vitro as described (17) . Mice were infected subcutaneously into one hind foot pad with 2 x 106 L. major stationary-phase promastigotes in a final volume of 50 #1. The development of lesions was monitored by measuring, with a vernier caliper, the increase in foot pad thickness compared with the uninfected controlateral foot pad. At selected times, the number of viable parasites in infected tissues was also measured by use of a parasite-limiting dilution assay previously described (18) . In some experiments, mice were treated intraperitoneally with 2 mg XMG 1.2 anti-IFN-3~ mAb (19) 2 d before infection and with 320 #g of mAb weekly for 3 wk after infection. Lymphocyte Cultures. LN and spleen cell suspensions were stimulated, at the indicated cell numbers, with 4 x 106 UV-irradiated L. major promastigotes in a final volume of 1 ml at 37~ and an atmosphere of 7% COz. Cells were cultured in DMEM supplemented with 5% heat-inactivated FCS, t-glutamine (216 rag/m1), 5 x 10-s M 2-ME, and 10 mM Hepes. Culture supernatants were collected after 18-72 h of stimulation and stored at -20~ until use. Similar experiments were also carried out with CD4 + T cell-depleted populations. Depletion of CD4 + cells was accomplished by treatment of 5 x 107 cells with an anti-CD4 IgM mAb (RL-172.4 [20] , a gift of H. R. MacDonald, Ludwig Institute for Cancer Research, Epalinges, Switzerland) and rabbit complement (Low-Tox; Cederlane, Horuby, Canada).
Detection of lFN-'y and IL4 in Culture Supernatant. IFN-3' was measured by ELISA as previously described (21) . Ib4 was measured by a bioassay using the CT.4S cell line as described (22 PCR Analysis. First-strand cDNA synthesis was preformed on 1/~g total RNA by use of a first-strand cDNA kit (Pharmacia). PCR was performed directly on the first-strand cDNA by use of Taq DNA polymerase (Boehringer Mannheim, Mannheim, Germany) according to the manufacturers specifications with II.-4-and GAPDH-specific primers described previously (29) . The level of IL-4 message was normalized between samples with the level of GAPDH message used as a control. mice (Table 2) . On day 40, significantly larger amounts of IFN-7 were produced by both LN and spleen cells from IFN-3,R-/-mice. The IFN-T was produced by CD4 + T cells since depletion of these T cells from both LN and spleen cell populations abrogated the production of IFN-7 upon specific stimulation ( Table 2 ). The release of high amounts of IFN-7 by specifically stimulated CD4 + T cells from IFN-TR-/-mice 40 d after infection could not only be the result of an increased frequency of these cells, but could also be a consequence of the inability of cells from these mice to absorb some of the IFN-7 produced in cultures. Therefore, the number of CD4 § T cells producing IFN-y upon specific stimulation in vitro was compared in the spleen and draining LN of infected IFN-TR-/-and IFN-TR +/+ mice by use of a quantitative ELISPOT assay that allows the detection of individual IFN-T-producing (18) . Results are from one of three experiments that gave similar results. * Foot pads from two mice were used for these determinations.
S LN cells (LNC) or spleen cells (SC) from four to eight mice were used for these determinations. (Fig. 2) . It is noteworthy that these cells were not detectable in noninfected mice (data not shown) and that their numbers were similar in IFN-3"K-/-and IFN-3'R + / + mice 20 d after infection (Fig. 2) . These results show that the increased IFN-3r production by CD4 + T cells from IFN-3'R -/-mice results from an increased frequency of responding cells.
We then investigated whether IFN-3rR-/-mice exhibited an expansion of Th2-type CD4 + T cells after infection with (Fig. 3) , which, however did not differ from the levels of expression in normal uninfected mice (data not shown). Interestingly, similar low (Fig. 4, right) was never observed when LN cells from IFN-q,R-/-mice were stimulated in the same manner at doses of IFN-3' as high as 1,000 U/ml (Fig. 4, le~) .
To further rule out the remote possibility that the IFN-3, produced in IFN-3,R-/-mice is driving the differentiation of CD4 + T cell precursors toward a Thl functional phenotype through a pathway not requiring the ligand-binding chain of its receptor, we studied the effect of administration of anti-IFN-y mAb to infected IFN-q,R -/-mice, at the time of initiation of infection, on the functional type of CD4 § T cells triggered. Anti-IFN-3, mAb was administered following a protocol shown to result in the modulation of the functional phenotype of CD4 + T cells triggered in resistant C3H mice (7) .
As shown in Fig. 5 , treatment with anti-IFN-'y mAb significantly increased both lesion size and parasite burden of IFN-yR +/ § mice to levels similar to those seen in IFN-3'R-/-mice not treated with antibodies. Although there was a slight, not significant, increase in lesion size in IFN-3'R-/-mice treated with anti-IFN-3, antibodies compared with untreated I F N -y R -/ -controls, there was no increase in parasite burden.
Enumeration of IFN-3,-producing cells by ELISPOT showed that anti-IFN-3, mAb treatment of both infected IFN-3,R -/-and IFN-3,R +/+ mice did not result in a decrease in the number of spleen or LN cells capable of producing IFN-3, upon specific stimulation in vitro (Fig. 6) . Similarly, Northern blot analysis of RNA from spleen and LN cells confirmed those results since no decrease in IFN-3' mRNA was observed after treatment of either IFN-'yR-/-or IFN-3,R § mice with anti-IFN-y mAb (Fig. 7) .
This treatment with anti-IFN-3, mAb did not lead to the expansion of IL-4-producing T cells since biologically active IL-4 could not be detected in supernatants of spleen or LN cells from infected IFN-q,R-/-and IFN-q,R +/+ mice after specific stimulation in vitro. Northern blot analysis shows that treatment of either IFN-q,R-/-or IFN-'yR + / + mice with anti-IFN-3, mAb did not have any effect on the level of expression of IL-4 mRNA (data not shown). As the level of IL-4 mRNA was always extremely low, we used a more sensitive RT-PCP, method in an attempt to detect IL-4 mRNA in uninfected and L. major-infected IFN-TR -/-and IFN-TR +/+ mice. RNA from infected BALB/c and C57BL/6 mice were used as reference controls. The level of IL-4 message in infected IFN-TR-/-and IFN-3'R + / + mice was similar to that seen in resistant C57BL/6 mice and significantly lower than that observed in BALB/c mice infected for the same period of time (Fig. 8) . Additionally, use of this technique confirmed that treatment with anti-IFN-'y mAb did not significantly modify the IL-4 mRNA levels in infected IFN-TP,-/-mice. Similarly, it is noteworthy that this treatment did not subseguently lead to enhanced levels of IL-4 message in IFN-TR +/+ mice.
Discussion
The results presented in this report confirm the crucial role of IFN-T in the elimination of L. major by infected hosts.
Indeed, macrophages are the only mammalian cells that support the growth of these parasites, and IFN-7 has dearly been shown to be the main lymphokine that activates macrophages to a parasiticidal state (2, 31) . The IFN-y-mediated destruction of intracellular L. major by macrophages has been demonstrated, in the mouse, to depend on the t-arginine-dependent production of NO by these cells (3, 4) . Thus, the severity of infection observed in IFN-TR-/-mice is consistent with previous results showing that macrophages from IFN-TR -/-mice did not release nitrites upon stimulation in vitro with IFN-7 either in the absence or the presence of
LPS (16).
Understanding of the mechanisms operating in the initiation of Thl or Th2 CD4 + T cell development from naive precursors is an important issue currently under investigation in several laboratories. Evidence, derived from in vitro and in vivo studies with various antigenic systems, exists for an important role of cytokines present at the initiation of primary CD4 + T cell stimulation on the differentiation of naive CD4 + T ceils toward one or the other functional phenotype.
Experimental infection of mice with L. major represents one of the first and best models of infection in which resistance and susceptibility were shown to correlate with the expansion and result from the activity of functionally distinct CD4 + T cell subsets (5, 6) . Furthermore, by use of this murine model of infection, it has also been suggested that cytokines present at the initiation of infection could direct the differentiation of CD4 + T call precursors toward one or For the first 20 d after infection, both parasite burden and IFN-T levels were similar in IFN-TR + / § and IFN-3~R-/-mice. However, compared with wild-type mice, significantly higher numbers of IFN-T-producing CD4 + T cells were observed in lymphoid tissues of mice lacking the IFN-~/R 40 d after infection. Since at this time the parasite burden was considerable in IFN-~/R-/-mice, it is likely that this increase in IFN-T production resulted in part from a strong and sustained antigenic stimulation. Recent evidence strongly indicates that L. major amastigotes are able to induce IL-12 p40 m R N A in macrophages (32) . Thus, it is likely that substantial amounts of IL-12 are generated as a result of the important number of amastigotes in IFN-TR -/ -mice and could account for the important production of IFN-T observed in these mice at later stages of infection with L. major, since IL-12 has been shown to stimulate IFN-T production by T and NK cells (33) . Production of substantial amounts of IL-12 in i F N -T R -/ -mice could also account for the suppression of an IL-4 response in these mice, since recent results have clearly shown that IL-12 strongly suppresses both base line and induced IL-4 gene expression (34) . However, one cannot completely rule out that a lack of appropriate regulation of IFN-3r production in mice unable to respond to this cytokine could also account, at least in part, for this increased production of IFN-3' observed in IFN-3,R-/-mice after various stimuli.
Our results are in line with observations showing that administration of recombinant IFN-3' to infected susceptible mice neither allowed the development of sustained Thl-type responses nor inhibited the expansion of Th2 cells (35) . In addition, infection ofttALB/c mice with parasites, into which the murine IFN-3' gene was introduced and expressed, led to the development of severe lesions and did not switch the polarized Th2-type response (36) . Furthermore, these results are in agreement with recent results showing that IFN-3,R -/-mice infected with pseudorabies virus develop a Thl-characteristic cytokine response (37) .
In contrast to these results, evidence for a role of IFN-y on the differentiation of Thl-type CD4 § T cells in the mufine model of infection with L. major also exists. Administration of anti-IFN-3r mAb at the time of parasite inoculation not only abrogated the natural resistance of C3H mice (2), but also ablated the Thl-type CD4 + T cell response normally seen in these mice and promoted the development of a Th2-type response (7). NK cells have been shown to be the major source of IFN-% produced early during infection of mice from some genetically resistant strains, possibly responsible for the expansion of Thl-type CD4 + T cells (38) . Finally, recent observations made in IFN-y-deficient C57BL/6 mice have revealed that these mice, in contrast to wild-type control mice, develop a Th2-type response after infection with L. major, without evidence of a Thl-type response (39) .
The reasons for the difference in the type of CD4 + T cell response triggered in IFN-qAk -/-(this study) and IFN-3' knockout mice (39) (Fig. 4) , an IFN-y-inducible surface marker (34) . In contrast, such treatment strongly induced the expression of this marker on LN cells from wild-type IFN-~/R. + / + mice. Furthermore, early treatment of IFN-3'R-/-mice with anti-IFN-3r mAb failed to result in a switch of the CD4 + T cell response toward the Th2 pathway. Treatment with anti-IFN-3, mAb was initiated before infection with L. major, following a regimen previously shown to result in the modulation of the functional phenotype of the CD4 + T ceils triggered in resistant C3H mice, consequently reversing their normal resistance to infection (7) . This effect was critically dependent on the timing of administration of anti-IFN-'y mAb, since treatment after infection was unable to alter the course of infection (2), strongly suggesting that the level of IFN-3' at the initiation of infection was crucial in determining whether a Thl or Th2 cytokine pattern subsequently developed (7) . It is important to emphasize that no detectable IFN-'y was produced by either IFN-qrR -/-or IFN-3,R +/+ mice at the time of infection. Furthermore, even during the early stages of infection, no evidence was obtained for the production of larger amounts of IFN-'y in IFN-yR -/-mice. Thus, it is likely that neutralization of IFN-qr by anti-IFN-qr mAb was similar, during the early stages of infection, in both IFN-3,R -/-and IFN-3,R +/+ mice. Taken together, these findings strongly suggest that the Thltype response observed in the present system is not mediated by IFN-y.
The implication of IFN-y in Thl cell development is based mainly on observations showing impairment of Thl responses in the absence of IFN-qr rather than on experiments demonstrating a promotion of sustained expansion of Thl cells by exogenous IFN-3'. In the absence of IFN-% the remote possibility that other lymphokines could bind to the IFN-qcR and transmit signals leading to the differentiation of CD4 + T cell precursors towards the Th2 pathway could be considered. Although the evidence for the specificity of the binding of IFN-y to its receptor is strong, a structural homology between the IFN-h'R and the receptor for IL-10 has recently been described (40) . Thus, it would be of interest to study the differentiations of T cell subsets after infection with L. major in transgenic mice that lack both the IFN-3, and the IFN-3,R genes. Finally, since the IFN-3, (39) and IFNyR knockout mice (this study) were derived on genetically different backgrounds, it is possible that the influence of IFN-y on the differentiation of T cell subsets may vary in different mouse strains. Such genetic differences in the importance of IFN-y for Thl-type response development could also account for the presently reported failure of anti-IFN-3, mAb, administered at the initiation of infection with L. major, to result in the differentiation of CD4 + T cell precursors toward the Th2 functional pathway, even in resistant wild-type IFN-3,R +/+ 129/Sv/Ev mice. Such treatment has indeed been shown to result in a shift in the T cell response from a Thlto a Th2-type response in resistant C3H/HeN mice infected with L. major (7) .
The importance of IL-12, a cytokine produced by cells with accessory or antigen-presenting function (41) , for the development of Thl-type CD4 + T cell responses after infection with L. major, has recently been recognized (42, 43) . Although the effect of IL-12 on Thl cell development in IFN-3'R-/-mice after infection with L. major has not yet been directly assessed, the results reported here suggest that such an effect of IL-12 would not be dependent on IFN-3,. These data are in agreement with other observations showing, on the one hand, the failure of IFN-y to modify the course of infection with L. major in susceptible mice (35) and, on the other hand, the capacity of IL-12 to cure these mice (42) . Moreover, in other antigenic systems the effect of IL-12 on the differentiation of Thl-type cells was unaffected by treatment with anti-IFN-y antibody (44) . Considering this important role of IL-12 in Thl cell development, it would be of great interest to compare its production after infection with L. major in IFNyR-/-and IFN-y knockout mice.
In other antigenic systems, the use of CD4 + T cells obtained from TCR-ot/B transgenic mice has facilitated the study of the parameters influencing short-term differentiation of CD4 § T cells after activation by specific antigen in vitro. The dominant effect of IL-4 in promoting the development of Th2-type responses was clearly demonstrated by observations showing that the addition of IL-4 during specific priming of CD4 + T cells from TCR-od/~-transgenic mice inhibited the development of Thl-type responses and led to the differentiation of Th2-type responses (12, 13) . Addition of IL-12 during specific priming of CD4 + T cells from TCR-ot/ B-transgenic mice led to the development of Thl-type responses (45, 46) .
In contrast to the well-accepted role of IL-4 and IL-12 on the development of Th2 and Thl responses, respectively, the data concerning the assessment of the importance of IFN-y in promoting the expansion of Thl cells are still unclear. By use of differentiated T cell clones, IFN-y has been demonstrated to selectively inhibit the proliferation of Th2 cells in vitro (30) . Using TCR-ot/fl-transgenic mice, some studies have shown a requirement for IFN-y in the development of CD4 + T cells producing high amounts of IFN-y by use of neutralizing antibodies against this cytokine, but have been unable to drive Thl-type cell development by addition of IFN-y to the priming cultures (47) . In these studies, CD4 § T cells from TCR-odB-transgenic mice on a BALB/c background were used. The requirement for IFN-y in Thl-type T cell development was, however, not shown in other studies with CD4 + T cells from other TCR-ot/B-transgenic mice on a B10 background, where IFN-y itself did not enhance priming for IFN-y production, nor did anti-IFN-3, reduce such priming (13) . Furthermore, even though evidence for an IFN-y dependence of the effect of IL-12 on the development of Thl-type response has been obtained in one TCRcff/5-transgenic system (47), the IL-12-mediated enhancement of priming for IFN-y production, also using an accessory ceU-dependent antigenic system with CD4 + T cells from other TCR-ot//5-transgenic mice, was not blocked by anti-IFN-y mAb (45) . However, in this study, upon stimulation of CD4 + T cells in an accessory cell-independent system, the ability of IL-12 to enhance production of IFN-y was substantially diminished in the presence of anti-IFN-7 antibodies (45). As CD4 + T cells from mice with different genetic backgrounds were used in these two studies, these results could reflect genetic differences in the importance of IFN-y in the regulation of T cell subset differentiation. Furthermore, they indicate that the requirements for priming in accessory cell-dependent and -independent systems may be different. In humans, IL-12 was also recently shown to promote Thltype response in an IFN-y-independent manner (48) .
In conclusion, the data presented here do not support a critical role for IFN-y in Thl cell development in vivo. They are in agreement with observations made in vitro that have led to the hypothesis that, in the absence of sufficient amounts of IL-4, the development of an IFN-y-producing CD4 + T cell response could represent the "default" pathway of differentiation of CD4 + T cell precursors (13). Thus, it is possible that the concentrations of IL-4 at the site of the developing lesion in IFN-yR-/-mice are not sufficient to either initiate priming for IL-4-producing T cell response or inhibit the differentiation of IFN-y-producing CD4 + T cells. Our results also underline the importance of mice genetically deficient in critical cytokine receptors for a better understanding of the factors regulating the T cell response to infectious pathogens.
